Updated October 25, 2026
| Name | Langotalk |
| Overview | Langotalk is an innovative AI-powered chat-based application designed to enhance language learning by allowing users to engage in immersive conversations. It uses AI conversation and feedback to support practice; the earlier six-times-faster claim is marketing, not an independently verified learning benchmark. The earlier article described positive learner experiences and lower-pressure practice. Such testimonials do not establish treatment for social anxiety or guarantee confidence gains. The current provider lists more than 20 languages and progress tracking. The earlier gamified-achievement description is historical; exact interface features may vary by version. The provider advertises quick signup and a free start; trial eligibility and renewal conditions depend on the offer selected. |
| Key features & benefits |
|
| Use cases and applications |
|
| Who uses? |
|
| Pricing | Web plans checked on October 25, 2026 show Monthly $29.99 per month, automatically renewing, without a trial on that selected offer. The annual option is $79.99 per year and advertises an eligible seven-day trial; the Lifetime option is displayed as a $149.99 one-time purchase. The annual monthly equivalent is not a month-to-month price. Confirm renewal and platform-specific terms before purchase; app-store offers may differ. |
| Tags | Language Learning, AI Tutor, Immersive Learning, Social Anxiety, Language Practice |
| App available? | Yes. Official publisher listings identify Langotalk for iPhone and Android, alongside its website. Platform and regional subscription offers may differ; a store’s download availability does not establish identical paid access everywhere. |
Sources: Current language coverage and learning features · Official web pricing route · Official iPhone listing · Official Android listing · Web trial, renewal and use conditions
Historical image: The existing Langotalk homepage uses a 3D avatar and a six-times-faster Spanish-learning claim. That is historical marketing, not an independently verified learning outcome or a treatment claim.
